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Massive parallel sequencing 
s u m m a r y 
Objectives: Guidelines for antibiotic treatment of acute cholecystitis are based on studies using culture 
techniques for microbial identification. Microbial culture has well described limitations and more com- 
prehensive data on the microbial spectrum may support adjustments of these recommendations. We used 
next generation sequencing to conduct a thorough microbiological characterization of bile-samples from 
patients with moderate and severe acute cholecystitis. 
Methods: We prospectively included patients with moderate and severe acute cholecystitis, undergoing 
percutaneous or perioperative drainage of the gall bladder. Bile samples were analyzed using both culture 
and deep sequencing of bacterial 16S rRNA and rpoB genes and the fungal ITS2-segment. Clinical details 
were evaluated by medical record review. 
Results: Thirty-six patients with moderate and severe acute cholecystitis were included. Bile from 31 
(86%) of these contained bacteria (29) and/or fungi (5) as determined by sequencing. Culture identified 
only 40 (38%) of the 106 microbes identified by sequencing. In none of the 15 polymicrobial samples 
did culture detect all present microbes. Frequently identified bacteria often missed by culture included 
oral streptococci, anaerobic bacteria, enterococci and Enterobacteriaceae other than Klebsiella spp. and 
Escherichia coli . 
Conclusions: Culture techniques display decreased sensitivity for the microbial diagnostics of acute chole- 
cystitis leaving possible pathogens undetected. 
© 2019 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 
This is an open access article under the CC BY-NC-ND license. 



















l  Introduction 
Acute cholecystitis is defined as an acute inflammation of the
gall bladder. It is one of the most common inpatient diagnoses at
surgical departments 1 , 2 and in more than 90% of patients it arises
as complications of cholelithiasis (calculous cholecystitis). 1 , 2 Bacte-
rial growth in bile is reported in 20% to 70% of patients. 3–8 Bacte-
rial infection is believed to represent a secondary complication and
not the initiating event of the disease. 2 Infection is considered an
important negative prognostic factor, and antibiotics are included
in treatment recommendations for all grades of severity. 4,7,9–11 ∗ Corresponding author. 
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( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) Empiric treatment with piperacillin/tazobactam or a
ephalosporin + / − metronidazole is recommended for moder-
te and severe acute cholecystitis irrespective of whether there is
rowth by culture. 9–11 The microbiological studies constituting the
asis for choosing these antibiotic regimens were all performed
ith conventional culture techniques. 10 For other purulent infec-
ions, recent comparisons of microbial detection by culture versus
ulture-free identification of microbial DNA by next generation
equencing (NGS) have demonstrated that conventional culture
etects only a fraction of the bacteria being present. 12 , 13 The
ower sensitivity is particularly pronounced for samples containing
naerobic bacteria and for samples collected after the initiation of
ntimicrobial therapy. 
Incomplete data on the microbial spectrum associated with
cute cholecystitis may lead to sub-optimal antibiotic treatment,
hus worsening patient outcome. A study from Israel found thation Association. This is an open access article under the CC BY-NC-ND license. 


















































































i  iscordant antibiotic therapy for acute cholecystitis, in most cases
ecause of a non-susceptible Enterobacter spp. or Enterococcus spp.,
esulted in a relative risk for in-hospital death of 6.28 compared to
atients who received concordant therapy. 7 
The aim of the present investigation was to use NGS to conduct
 thorough microbiological characterization of bile-samples from
linically well-characterized patients with acute cholecystitis. We
urther sought to compare the results from culture-free NGS with
esults obtained by conventional microbiological culture and dis-
uss discrepancies from a diagnostic and clinical perspective. 
aterials and methods 
We conducted a prospective, single-center study at Haukeland
niversity Hospital, Bergen, Norway. The study was approved by
he regional ethical committee (2015/65). Written informed con-
ent was obtained from all participants. 
atients 
From July 2015 to April 2017, we collected bile samples from 36
atients who underwent treatment with percutaneous (34) or pe-
ioperative (2) drainage for acute cholecystitis, defined according to
he Tokyo Guideline 2013 (TG13) criteria for a definite diagnosis. 14 
linical details were evaluated by medical record review. Although
ebated, 15 , 16 at Haukeland University Hospital acute mild chole-
ystitis is treated with observation and/or antibiotics, sometimes
ollowed by delayed cholecystectomy 2–4 months later. For mod-
rate and severe disease percutaneous drainage is the treatment of
hoice. Consequently, only patients with moderate or severe dis-
ase were available for inclusion, and percutaneous drainage was
he dominating sampling method. As a patient control group, we
ncluded bile samples taken at cholecystectomy from 16 patients
ith cholelithiasis and no signs of ongoing gallbladder inflamma-
ion, operated at Voss Hospital, Voss, Norway. 
ample material, routine diagnostics and DNA-extraction 
Bile fluid was aseptically collected during surgery or percuta-
eous drainage and injected into a sterile tube. All samples were
ultured according to the laboratory’s guidelines; 10 μl sample ma-
erial was spread on plates of blood agar, lactose agar, and fastid-
ous anaerobic agar with and without kanamycin and vancomycin.
n aliquot of bile was inoculated into brain heart infusion (BHI) as
n enrichment procedure. Blood agars and BHIs were incubated in
 CO2-enriched atmosphere for 48 h. Lactose agar was incubated
or 24 h. Anaerobe agars were incubated in an anaerobe atmo-
phere for 48 h. Isolates were identified by MALDI-TOF MS Bruker
icroflex (Bruker Biotyper, Bremen, Germany.) Table 1 
Criteria for sequence interpretations. 
Gene Species Species-
16S a ≥99.3% homology with a high-quality reference, 
and minimum distance > 0.7% to the next 




rpoB_Ent b ≥99.0% homology with a high-quality reference, 
and minimum distance > 1.5% to the next 




rpoB_ESS c ≥97.0% homology with a high-quality reference, 
and minimum distance > 2.0% to the next 




ITS-2 ≥99.0% homology with a high-quality reference, 





a V3-V4 region of 16S rRNA-gene. 
b rpoB-gene sequence targeted at Enterobacteriaceae. 
c rpoB-gene sequence targeted at Staphylococcus, Enterococcus and Streptococcus speciDNA was extracted from each sample using a volume of 400 μl
ile as described previously. 17 The eluate was stored at −80 °C for
ater NGS analysis. 
assive parallel sequencing of 16S rRNA, ITS2 and rpoB genes 
Sequencing of partial bacterial 16S rRNA and the fungal ITS2-
egment were performed from all samples. Sequencing of partial
poB -genes were done whenever 16S rRNA sequencing revealed
acteria from the Enterobacteriaceae family or from the Enterococ-
us, Streptococcus or Staphylococcus genera that could be identified
t a higher taxonomic level by the selected rpoB -gene segments. 13 
mplification and sequencing of 16S rRNA- and rpoB -genes was
erformed as described previously using the Illumina MiSeq sys-
em (Illumina, Redwood City, CA). 13 For the fungal ITS2-segment
e used the primers recommended by Khot et al. 18 and otherwise
ollowed the protocol as described for 16S rRNA. 13 All primers are
isted in Supplementary Table S1. 
egative controls 
Each clinical sample was processed together with a parallel
egative extraction control consisting of lysis buffer and PCR-grade
ater. Before sequencing, the negative extraction controls were
ixed into three pools. A positive extraction control consisting of
egionella pneumophila suspended in PCR-grade water was also in-
luded and sequenced in the same run. 
equence data analysis 
After Illumina-sequencing, barcode separated FASTQ-files were 
rocessed using the RipSeq NGS software 12 (Pathogenomix, Santa
ruz, CA) where sequences were de novo clustered into operational
axonomic units (OTUs) using a similarity threshold of 99%. OTUs
ontaining less than 50 sequences were rejected. 13 Criteria for se-
uence interpretations are provided in Table 1 . 
ackground DNA 
Management of background contaminant bacterial DNA was
one as described previously. 13 There was a high consistency
cross all negative and positive extraction controls for the domi-
ant contaminant bacterial species. 
Background contaminant fungal DNA showed a higher variation
cross negative and positive extraction controls. For management
f background fungal DNA, we defined a list of the ten most abun-
ant contaminating fungi based on results from negative and pos-
tive extraction controls. Additionally, the laboratory keeps a list ofgroup Genus 
homology with a high-quality reference, 
inimum distance ≤0.7% to the next 
ative species. 
> 97.0% homology with a 
high-quality reference 
homology with a high-quality reference, 
inimum distance ≤1.5% to the next 
ative species 
Not applicable 
homology with a high-quality reference, 
inimum distance ≤2.0% to the next 
ative species. 
Not applicable 
homology with a high-quality reference, 















































(  common contaminant fungi based on previous sequencing of neg-
ative and positive extraction controls. Fungi appearing in higher
concentrations than any of these contaminants were accepted as
valid identifications. 
Statistical analysis 
Statistical analyses were performed using SPSS 25 (IBM Corp).
Clinical and microbial differences between subgroups were ana-
lyzed with Pearson’s chi squared test for categorical data. For con-
tinuous data the Student ́s t -test was used for normal distributed
variables and Mann-Whitney U test for skewed variables. 
Results 
Clinical description of patients 
Thirty-six patients – 19 (53%) males and 17 (47%) females –
were included. The mean age was 70 years (median 72, range
37–94). Clinical and demographic characteristics together with
main microbiological findings are presented in Table 2 . Patients
were categorized as having either moderate (24) or severe (12)
acute cholecystitis according to the TG18/TG13 severity assess-
ment criteria 19 (Supplementary Table S2). Compared to the mod-
erate disease group, patients in the severe disease group were
older, scored higher on Charlson’s comorbidity index 20 and had
higher prevalence of Streptococcus spp. and Enterobacteriaceae
other than Klebsiella spp. and E. coli . Antibiotic treatment had been
initiated for all patients except one prior to sample collection.Table 2 
Characteristic, sequencing and culture results for all 
Patient group 
Demographic and clinical characteristics 
Number of patients 
Male 
Mean age (SD; median; min–max), years 
Community-acquired 
Mean CCI a (SD; median; min–max) 
Gall bladder stone 
Bile duct stone 
Concomitant acute cholangitis 




Sequencing and culture results 
Samples with detected microbes by sequencin
Samples with growth in bile culture 
Samples with detected bacteria by sequencing
Samples with detected fungi by sequencing 
Polymicrobial samples by sequencing 
Major groups of bacteria detected by sequenc
Samples with Klebsiella spp. 
Samples with E. coli 
Samples with Enterobacteriaceae other than
Klebsiella spp. and Escherichia coli 
Samples with Enterococcus spp. 
Samples with Streptococcus spp. 
Samples with anaerobic bacteria 
Patient control-group 
Number of patients 
Male 
Mean age (SD; median; min–max), years 
Mean CCI a (SD; median; min–max) 
Samples with detected microbes by sequencin
and/or culture 
Species detected 
Bifidobacterium animalis (detected by) 
Streptococcus parasanguinis (detected by) 
Haemophilus parainfluenzae (detected by) 
a CCI = Charlsons comorbidity index. iperacillin/Tazobactam was the most frequently administered an-
ibiotic, being part of or the only antimicrobial treatment for 28
atients. Eleven patients were diagnosed with local complications
ncluding marked local inflammation and/or perforated cholecys-
itis. The microbial findings by both NGS and culture from these
atients can be found in Supplementary Table S3. Individual clin-
cal characteristics, microbial findings and antibiotic treatment are
rovided in Supplementary Table S4. One patient died during hos-
ital stay (Patient number 26, Supplementary Table S4). This pa-
ient had no detectable microbe in bile, neither by culture nor by
equencing. 
Characteristics of the patient-control group are detailed in
able 2 . Only three (19%) out of the 16 controls had detectable
icrobes in bile; Streptococcus parasanguinis, Bifidobacterium ani-
alis and Haemophilus parainfluenzae were identified in one sam-
le each. 
echnical sequencing data 
For the 16S rRNA amplicon the mean number of accepted reads
er sample was 145,155 (range 28,592–404,981, median 115,519)
fter removal of short reads ( < 250 base pairs), small clusters ( < 50
eads) and chimeras. For the ITS2 amplicon the corresponding
umber was 23,024 (range 5150–47,568, median 15,514). 
icrobial findings 
Thirty-one samples (86%) contained bacteria (29) and/or fungi
5) as determined by sequencing ( Table 2 ). Among these, fivepatients. 
36 
19 (53%) 
70 (16; 72; 37–94) 
30 (83%) 







g 31 (86%) 
26 (72%) 












53 (18; 55; 20–79) 
0,25 (0,5; 0; 0–1) 
g 3 
1 (sequencing and culture) 
1 (sequencing and culture) 
1 (sequencing) 
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Table 3 
Species identified at a higher taxonomic level with use of partial rpoB -gene compared to partial 16S rRNA gene sequencing (V3–V4). 
16S rRNA gene sequencing results rpoB- gene sequencing results 
1 Citrobacter werkmanii/Citrobacter freundii/Citrobacter braakii/Citrobacter pasteurii/Kluyvera 
ascorbata 
Citrobacter sp. 
2 Klebsiella michiganensis/Enterobacter ludwigii/Enterobacter asburiae/Enterobcater 
cloacae/Enterobacter kobei/Citrobacter freundii/Salmonella enterica 
Enterobacter asburiae/Enterobacter 
cloacae/Enterobacter kobei 
3 Enterobacter asburiae/Enterobacter cloacae/Enterobacter hormaechei/Klebsiella 
michiganensis/Klebsiella oxytoca/Klebsiella pneumoniae/Klebsiella quasipneumoniae 
Enterobacter cloacae/Enterobacter hormaechei 
4 Enterococcus gallinarum /Enterococcus casseliflavus Enterococcus casseliflavus 
5 Enterococcus durans/Enterococcus faecium/Enterococcus hirae Enterococcus faecium 
6 Escherichia coli/Escherichia albertii/Escherichia fergusonii/Shigella species Escherichia coli/Shigella sp. 
7 Hafnia alvei/Hafnia paralvei/Ewingella americana Hafnia alvei 
8 Klebsiella michiganensis/Klebsiella oxytoca/Enterobacter asburiae/Enterobacter 
cloacae/Enterobacter hormaechei 
Klebsiella michiganensis 
9 Klebsiella michiganensis/Klebsiella oxytoca/Enterobacter asburiae/Enterobacter 
hormaechei/Enterobacter cloacae/Salmonella enterica 
Klebsiella oxytoca 
10 Klebsiella aerogenes/Enterobacter asburiae/E. cancerogenes/Enterobacter cloacae/Enterobacter 
hormaechei/Enterobacter ludwigii/Enterobacter xiangfangensis/Klebsiella 
pneumoniae/Klebsiella oxytoca/Klebsiella michiganensis/Klebsiella variicola 
Klebsiella pneumoniae/Klebsiella 
quasipneumoniae 
11 Klebsiella pneumoniae/Klebsiella variicola Klebsiella variicola 
12 Proteus hauseri/Proteus penneri/Proteus vulgaris Proteus vulgaris 
13 Salmonella enterica/Enterobacter cloacae/Enterobacter kobei/Enterobacter ludwigii/Citrobacter 
amalonaticus/Klebsiella michiganensis 
Salmonella enterica 
14 Streptococcus anginosus/Streptococcus intermedius Streptococcus anginosus 
15 Streptococcus gordonii/Streptococcus cristatus Streptococcus gordonii 
16 Streptococcus mitis/oralis group Streptococcus mitis 
17 Streptococcus mitis/oralis group Streptococcus oralis 
18 Streptococcus sanguinis group Streptococcus parasanguinis 
19 Streptococcus salivarius group Streptococcus salivarius 
20 Streptococcus sanguinis group Streptococcus sanguinis 






































































r  amples were culture negative. From the 106 microbial detections
ade by sequencing (100 bacteria and 6 fungi), only 40 were cul-
ured (38%). The 100 bacteria detected by sequencing represented
3 different species of which 38 were identified to the species
evel, 14 to a species group level, and 1 to the genus level. The rpoB
ene improved identification for 21 species ( Table 3 ). Two bacte-
ial identifications were made by culture alone, one Klebsiella pneu-
oniae and one Staphylococcus epidermidis . A detailed comparison
f identifications made by sequencing versus culture is provided
n Table 4 . Table 5 provides an overview of the bacterial genera
ound in each patient and the proportion of samples containing
ach genus. In patients with polymicrobial infections culture failed
o detect one or more microbes in all 15 samples (Supplementary
able S4). For the monomicrobial infections, there was a higher
oncordance (81%) between culture and sequencing. Only three of
he 16 monomicrobial samples were culture negative (Supplemen-
ary Table S4). 
Six fungi were identified by sequencing ( Table 4 ) whereof one,
 Candida albicans , was also cultured. Two samples were mo-
omicrobial containing C. albicans ; one severe postoperative acal-
ulous cholecystitis after pancreatic cancer surgery who also had
. albicans in blood culture, and one community-acquired calcu-
ous cholecystitis of moderate severity. The other identified fungi,
accharomyces cerevisiae (2), C. albicans (1) and Candida humilis (1)
ere part of poly-microbial infections (Supplementary Table S4).
nly the patient with severe postoperative acalculous cholecystitis
eceived antifungal treatment. 
Blood culture samples were collected from 24 patients whereof
ve had a detectable bacteremia (Supplementary Table S4). Antibi-
grams of all bacteria cultured from bile or in blood culture are
rovided in Supplementary Table S5. 
iscussion 
To the best of our knowledge, this is the first study that uses
GS for microbial characterization of bile samples from patientsith acute cholecystitis, with the exception of a small study on six
atients. 21 This is also the first study to describe the bacteriology
f severe acute cholecystitis according to the TG18/TG13 severity
rading. 5 , 8 
Although bactobilia is considered a negative prognostic factor in
cute cholecystitis, there is, with the exception of the aforemen-
ioned Israeli study, 7 little evidence on the clinical importance of
he individual bacterial species. In many of the polymicrobial sam-
les in our study, the relative abundance of the identified bacteria
aried widely ( Table 5 ). Some might dismiss the clinical relevance
f low abundance species in complex infections, in particular if
ound be sequencing only. However, several of the bacteria iden-
ified were anaerobic, fastidious, slow growing and/or antibiotics-
ffected, and their failure to survive and grow in the laboratory
oes not mean that they are eradicated from the infection site nor
hat they are of lower clinical relevance. We would also like to
oint out that abundant growth does not necessarily reflect in-
ivo dominance but might as well reflect a microbe’s ability to
hrive and compete during transportation and cultivation. We have
requently observed, also in this study, that bacteria with abun-
ant growth constitute only minor parts of the population as de-
ermined by sequencing or that a dominant microbe as determined
y sequencing fails to grow. In our opinion, the clinical relevance
f individual bacteria in complex infections should not be con-
idered based on relative quantifications or by method of detec-
ion. Rather, such inference should be based on in-depth ecological
nowledge of each type of infection, including microbial dynam-
cs over time, microbial aggregate formation, metabolic interdepen-
encies and synergisms. 22 , 23 Complete microbial characterizations
s provided in this study represent the first step in obtaining such
nowledge but needs to be followed up by both experimental stud-
es and larger clinical studies. 
Except for Klebsiella spp. and E. coli , we found that 50% of
pecies in the Enterobacteriaceae family, including species from
he genera Citrobacter, Enterobacter, Proteus, Hafnia, Salmonella, Ser-
atia, Morganella and Raoultella remained undiscovered by culture
20 R. Dyrhovden, K.K. Øvrebø and M.V. Nordahl et al. / Journal of Infection 80 (2020) 16–23 
Table 4 
Identified bacteria and fungi from bile samples by sequencing compared to conventional culture. 
Total number of identifications 
by sequencing (% of all 
microbial detections) 
Growth by culture 
Total identifications 106 40 
Gram negative a 41 (39%) 23 
Klebsiella 11 (10%) 9 
pneumoniae/quasipneumoniae 3 3 
Michiganensis c 3 2 
Oxytoca c 3 2 
Variicola c 2 2 
Escherichia coli b , c 10 (9%) 9 
Campylobacter 4 (4%) 0 
Concisus 1 0 
Concisus/mucosalis 1 0 
Curvus 1 0 
Rectus/showae 1 0 
Citrobacter 3 (3%) 1 
Species c 2 1 
Amalonaticus/farmeri 1 0 
Haemophilus parainfluenzae 3 (3%) 0 
Enterobacter 2 (2%) 1 
Asburiae/cloacae/kobei c 1 1 
Cloacae/hormaechei c 1 0 
Morganella morganii 2 (2%) 1 
Hafnia alvei c 1 (1%) 0 
Proteus vulgaris 1 (1%) 1 
Pseudomonas aeruginosa/otidis 1 (1%) 1 
Raoultella ornithinolytica/planticola 1 (1%) 0 
Salmonella enterica c 1 (1%) 0 
Serratia marcescens 1 (1%) 0 
Gram positive a 35 (33%) 14 
Streptococcus 15 (14%) 6 
Anginosus c 3 1 
Salivarius c 3 2 
Sanguinis c 2 1 
Gordonii 1 1 
Massiliensis 1 1 
Mitis c 1 0 
Mutans 1 0 
Oralis c 1 0 
Parasanguinis c 1 0 
Termophilus c 1 0 
Enterococcus 11 (10%) 5 
Faecalis 4 2 
Faecium c 4 2 
Avium/raffinosus c 2 1 
Casseliflavus c 1 0 
Lactobacillus casei/paracasei/rhamnosus 4 (4%) 3 
Actinomyces 5 (5%) 0 
Gerencseriae 1 0 
Naeslundii/oris 1 0 
Naeslundii/oris/johnsonii 1 0 
sp. (oral taxon 848) 1 0 
Turicensis 1 0 
Anaerobic 24 (23%) 2 
Clostridium perfringens 5 (5%) 2 
Fusobacterium nucleatum 5 (5%) 0 
Bifdobacterium 4 (4%) 0 
Animalis 2 0 
Dentium 1 0 
Longum 1 0 
Veillonella 3 (3%) 0 
Dispar/parvula 2 0 
Parvula/tobetsuensis/dentocariosa 1 0 
Intestinibacter bartletti 3 (3%) 0 
Slackia exigua 1 (1%) 0 
Dialister invisius 1 (1%) 0 
Bilophila wadsworthia 1 (1%) 0 
Propionibacterium acidifaciens 1 (1%) 0 
Fungus 6 (6%) 1 
Candida 4 (4%) 1 
Albicans 3 1 
Humilis 1 0 
Saccharomyces cerevisiae 2 (2%) 0 
a One K. pneumoniae and one S. epidermidis detected exclusively by culture is not included in table. 
b Not distinguishable from Shigella spp . 




























































Heatmap of all bacterial genus identified in each patient. Only samples containing bacteria are included in the table. 


















































































































( Table 4 ). These bacteria are generally considered clinically rele-
vant and there is evidence to support their role in the pathogen-
esis of acute cholecystitis. 24 For Enterobacter spp. there is also a
possible association with a poorer patient outcome. 7 The capability
of acquiring or inducing antibiotic resistance, and a high frequency
of multi-resistant clones among some Enterobacteriaceae, increases
the likely clinical benefit of identifying these bacteria. 25 
Only five out of eleven enterococci were found by conven-
tional culture ( Table 4 and Supplementary Table S4). The clini-
cal significance of enterococci in acute cholecystitis and in intra-
abdominal infections in general remains uncertain. Most empiric
guidelines for antibiotic treatment of acute cholecystitis do not
include specific enterococcal coverage, 9 , 11 except for the Tokyo
Guidelines’ recommendation of adding vancomycin for severe
cholecystitis. 10 However, in complicated acute cholecystitis and/or
severely ill patients it is recommended to use microbiology cul-
ture results to guide antimicrobial treatment. 10 , 11 , 26 This implies
that if the enterococci found only by sequencing in our cohort
had also been found by culture, it might have led to an ad-
justment of antibiotic treatment. As mentioned, failure to cul-
ture microbes does not mean that they have been eradicated
from the infection site. Future studies addressing the relevance of
enterococci should therefore not rely on culture-based diagnos-
tics alone but also include molecular approaches like sequencing
or PCR. 
Anaerobic bacteria may be sub-optimally covered by
monotherapy with a third-generation cephalosporin whereas
Piperacillin/tazobactam provides good coverage of anaerobic bac-
teria. In this study, NGS detected 24 anaerobic bacteria from
10 samples whereof only two (8%) were also detected by cul-
ture ( Table 4 ). The two most common anaerobe species were
Clostridium perfringens and Fusobacterium nucleatum. Clostridium
perfringens is known for its pathogenicity and its ability to cause
emphysematous cholecystitis. Fusobacterium nucleatum has to the
best of our knowledge not previously been reported in acute
cholecystitis but is considered an important anaerobe pathogen
in both odontogenic infections, pleural empyemas and brain
abscesses. 12 , 13 
In healthy individuals, the bile is considered to be sterile, 27–29 
but gallstone disease might lead to bacterial colonization. Culture-
based studies report bacteria in between 9% and 54% of patients
with gallstone disease without infection. 6 , 28 , 29 Two NGS-based
studies addressing this issue report conflicting results. One study
found a very high rate of colonization (100%) and suggest the ex-
istence of a bile core microbiome comprising 208 Operational Tax-
onomic Units (OTUs)/species. 30 Another study found the rate of
colonization to be 13% with a mean bacterial diversity of 5 OTUs
per sample. 31 Both studies fail to explain how they addressed the
problem of contaminant background DNA, chimera formation and
sequencing noise. These are fundamental challenges in microbiome
studies and will significantly inflate microbial diversity if not con-
sidered properly. 32 , 33 In our patient control group only three (19%)
bile samples were colonized, each with a single bacterial species
( Table 2 ), providing little support for the existence of a bile micro-
biome. 
Some limitations to this study should be noted. It is a single
center investigation with a relatively low number of patients, and
the general validity of our results therefore needs confirmation by
other studies. The patients in our cohort were also of higher mean
age than in historic studies on moderate and severe cholecysti-
tis which may in part explain the higher rate of bactobilia ob-
served. 4 , 5 , 29 Due to the severity of the disease, antibiotic treatment
had been initiated for most patients prior to sample collection. Al-
though bacterial DNA is very stable in undrained purulent infec-
tions this might still have impacted the observed relative abun-
dancies of species in the polymicrobial infections. We have shown that culture-based methods alone are insuf-
cient in the microbiological diagnostics of moderate and severe
cute cholecystitis, leaving more than 60% of the microbes unde-
ected. The clinical consequences of not detecting or treating all
hese bacteria should be further addressed in future studies as
hould eventual consequences for empiric treatment recommenda-
ions. Yet, clinicians should be aware of the risk of leaving clini-
al important bacteria untreated if antimicrobial treatment is cus-
omized based on culture results only. For anaerobic bacteria, the
ow recovery rate may imply that anaerobic coverage should be
onsidered regardless of a negative anaerobic culture. This and
ther studies emphasize the need for rapid and reliable culture-
ndependent microbial detection and susceptibility testing in diag-
ostic microbiology. 
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